Overview


Patients who require support in breathing, treatment to reduce abdominal wall muscle atrophy, or therapy to remove carbon dioxide from their lungs, may need respiratory assist devices. The respiratory or pulmonary devices are used for the removal of mucus or secretions from the respiratory tract or airways. These devices focus on diagnosing, controlling, treating, managing, and evaluating problems related to the respiratory tract. Market growth is driven by factors such as an increase in respiratory diseases, rising geriatric populations, sedentary lifestyles, high levels of smoking, increased pollution levels, urbanization, and a rise in the prevalence of these conditions. The market growth is slowed by reimbursement issues and the harmful effects of certain respiratory devices on newborns. The market growth opportunities are also increased by the rising demand for home care therapeutic devices, and the growth of healthcare in developing countries. The market will also see an increase in the use of advanced safety and technological features for pulmonology devices. The adoption rate has increased significantly due to the increasing awareness of the dangers of lung cancer and the benefits that early treatment can bring. Due to the increasing numbers of elderly people around the globe, the adoption of therapeutic and diagnostic pulmonology devices will continue to grow. The market will grow due to the increasing prevalence of respiratory diseases such as lung cancers, asthma, and chronic obstructive pneumonia disorders (COPD), which each year is increasing.
FutureWise Market Research has instantiated a report that provides an intricate analysis of Pulmonary Devices Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the Pulmonary Devices Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.
• GlaxoSmithKline Plc
• 3M
• Medtronic Plc
• Koninklijke Philips N.V>
• ResMed Inc
• Masimo Corporation
• Thermo Fisher Scientific
• Fisher and Paykel Healthcare Limited
• Becton Dickinson and Company
• Hamilton Medical AG
(Note: The list of the major players will be updated with the latest market scenario and trends)
By Type
• Therapeutic Devices
o Humdifiers
• Heated Humdifiers
• Passover Humdifiers
o Oxygen Concentrators
• Fixed Oxygen Concentrators
• Portable Oxygen Concentrators
o Positive Airway Pressure (PAP) Devices
• Continuous PAP Devices
• Automatic PAP Devices
• Bi-level PAP Devices
o Resuabel Resuscitators
• Adult Resusucitators
• Infannt/Neonatal Resusucitators
o Ventilators
• Adult Ventilators
• neonantal ventilators
o Masks
• Nasal Masks
• Full-face Maska
• Nasal Pillow Masks
• Oral masks
o Inhalers
• Metered Dose Inhalers
• Dry Powder Inhaler
o Nebulizers
o Nitirc Oxide Delivery Units oxygen hoods
• Consumables and Accessories
o Disposale Masks
o Disposable Resuscitators
o Tracheostomy Tubes
o Nasal Cannulas
o Others
• Diagnostic Devices
o Spirometer
o Peak Flow Meters
o Polysomnography Devices
o Others
• Monitoring Devices
o Pulse Oximeters
• Pulse Oximeter Sensors
• Pulse Oximeter Equipment
o Capnographs
o Gas Analyzers
By End-User
• Hospitas
• Ambulatory Care
• Home Care
By Region
• North America
• Europe
• Asia-Pacific
Latin America
• Middle East and Africa
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth
• To provide with an exhaustive analysis on the Pulmonary Devices Market By Type, By End-User and By Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Pulmonary Devices Market Variables, Trends
    • Scope
        1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Type Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances
  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Pulmonary Devices Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Pulmonary Devices Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Type Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Type Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Pulmonary Devices Market, By Type Historical Analysis and Forecast 2022-2028 (USD Million)
    •   1. Therapeutic Devices
         1.1. Humdifiers
          1.1.1. Heated Humdifiers
          1.1.2. Passover Humdifiers
         1.2. Oxygen Concentrators
          1.2.1. Fixed Oxygen Concentrators
          1.2.2. Portable Oxygen Concentrators
         1.3. Positive Airway Pressure (PAP) Devices
          1.3.1. Continuous PAP Devices
          1.3.2. Automatic PAP Devices
          1.3.3. Bi-level PAP Devices
         1.4. Resuabel Resuscitators
          1.4.1. Adult Resusucitators
          1.4.2. Infannt/Neonatal Resusucitators
         1.5. Ventilators
          1.5.1. Adult Ventilators
          1.5.2. neonantal ventilators
         1.6. Masks
          1.6.1. Nasal Masks
          1.6.2. Full-face Maska
          1.6.3. Nasal Pillow Masks
          1.6.4. Oral masks
         1.7. Inhalers
          1.1. metered Dose Inhalers
          1.2. Dry Powder Inhaler
         1.8. Nebulizers
         1.9. Nitirc Oxide Delivery Units oxygen hoods
        2. Consumables and Accessories
         2.1. Disposale Masks
         2.2. Disposable Resuscitators
         2.3. Tracheostomy Tubes
         2.4. Nasal Cannulas
         2.5. Others
        3. Diagnostic Devices
         3.1. Spirometer
         3.2. Peak Flow Meters
         3.3. Polysomnography Devices
         3.4. Others
        3. Monitoring Devices
         3.1. Pulse Oximeters
          3.1.1. Pulse Oximeter Sensors
          3.1.2. Pulse Oximeter Equipment
         3.2. Capnographs
         3.3. gas Analyzers
  • 8.   Pulmonary Devices Market, By End-User Historical Analysis and Forecast 2022-2028 (USD Million)
    •   1. Hospitas
        2. Ambulatory Care
        3. Home Care
  • 9.   North America Pulmonary Devices Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
           2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2022-2028
  • 10.   Latin America Pulmonary Devices Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2022-2028
  • 11.   Europe Pulmonary Devices Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         2.1. Germany
          2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2022-2028
  • 12.   Asia Pacific Pulmonary Devices Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028
  • 13.   Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2022-2028
  • 14.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 15.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. GlaxoSmithKline Plc
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. 3M
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Medtronic Plc
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
         4. Koninklijke Philips N.V>
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. ResMed Inc
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Masimo Corporation
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Thermo Fisher Scientific
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Fisher and Paykel Healthcare Limited
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Becton Dickinson and Company
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10.Hamilton Medical AG
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
  • 16.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 17.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients